What Happens at a Rheumatology Appointment?

Navigate your first rheumatology visit with confidence. Learn what to expect when seeing a specialist for musculoskeletal or autoimmune conditions.

A first rheumatology appointment is longer and more thorough than most specialist visits, typically lasting 45 minutes to an hour. The rheumatologist will take a detailed medical history, physically examine your joints and sometimes your skin, eyes, and nails, order blood work and possibly imaging, and begin forming a diagnosis or a plan to reach one. Because rheumatic diseases affect many body systems and can mimic each other, the visit often feels like a head-to-toe investigation rather than a quick look at whatever hurts.

How You Get Referred in the First Place

Most people see a rheumatologist because their primary care doctor spotted something that needs specialized evaluation. A systematic review of referral criteria found that the most common reason for a rheumatology referral is swollen joints, appearing in about four out of five referral guidelines, followed by joint pain or stiffness and tender joints. Lab results also play a role: roughly half of published referral criteria include inflammatory markers like C-reactive protein or sedimentation rate, and about half consider rheumatoid factor. But joint inflammation is not the only ticket in. A qualitative study that built consensus referral criteria identified seven distinct pathways, including chronic low-back pain lasting over three months in people under 45, suspected autoimmune disease, osteoporosis, and complications of rheumatologic treatment already underway.

In practical terms, if your doctor noticed persistent swelling, unexplained inflammatory blood markers, or symptoms that point toward an autoimmune process, that is usually why you are sitting in a rheumatology waiting room.

The Medical History Interview

Expect the history-taking portion to be the longest part of the visit. Rheumatic diseases can show up in almost any organ system, so the rheumatologist asks about far more than your joints. A clinical review describes the rheumatological history as the “key diagnostic tool,” requiring a wide-lens approach that covers past and present symptoms across multiple body systems alongside more targeted questions about specific features. You will likely be asked about:

  • Joint symptoms: which joints hurt, when the pain started, whether it is worse in the morning or after rest, and whether the pattern is symmetric (the same joints on both sides).
  • Systemic symptoms: fatigue, fevers, unintentional weight loss, rashes, dry eyes or mouth, hair loss, and sensitivity to cold in the fingers.
  • Family history: autoimmune diseases often cluster in families, so expect questions about relatives with lupus, rheumatoid arthritis, psoriasis, or inflammatory bowel disease.
  • Functional impact: how well you can grip, walk, dress yourself, and get through your daily routine.

Rheumatology history-taking places heavy emphasis on the onset of joint pain, its pattern, symmetry, and the number of joints involved, because those details help narrow a long list of possible diagnoses. A sudden flare in a single big joint points toward gout or infection, while a gradual, symmetric involvement of small joints in both hands suggests rheumatoid arthritis. The more precise your answers, the more efficiently the visit goes.

The Physical Examination

After the history, the rheumatologist will examine you. The core of the exam is a joint-by-joint assessment. In a standard 28-joint count used for conditions like rheumatoid arthritis, the doctor checks the shoulders, elbows, wrists, knuckles, the middle finger joints, and the knees for both swelling and tenderness. They will squeeze your hands and feet, bend and rotate your joints, and press on specific spots. This is not just about pain. The doctor is feeling for the spongy, boggy texture of inflamed tissue, checking range of motion, and looking for deformities that suggest longstanding disease.

The exam often extends well beyond the joints. Rheumatoid arthritis alone can involve the skin, eyes, heart, lungs, kidneys, and nervous system. Other rheumatic conditions have their own set of non-joint features. The doctor may check your nails for pitting (a sign of psoriatic arthritis), feel for enlarged lymph nodes, listen to your heart and lungs, and look at the skin on your elbows, shins, and scalp. If you have a rash or sore you think might be relevant, point it out even if it seems unrelated.

Blood Tests the Rheumatologist Orders

After or even before the physical exam, the rheumatologist will order lab work. Blood draws may happen right in the office or at a nearby lab. The specific tests depend on what diagnosis the doctor suspects, but a few categories come up in nearly every initial workup.

Autoantibody Tests

Two tests dominate when rheumatoid arthritis is on the table: rheumatoid factor and anti-CCP antibodies. A meta-analysis found that anti-CCP antibodies have a sensitivity of about 67% and a specificity of roughly 95%, meaning they miss about a third of RA cases but rarely produce false positives. Rheumatoid factor is slightly more sensitive but less specific. When the two tests are used together, their combined positive predictive value approaches 100%, and both are part of the current classification criteria for rheumatoid arthritis. Anti-CCP values also track with disease severity over time and tend to be higher in patients who go on to develop complications.

For other conditions, different antibodies get tested. ANA (antinuclear antibody) is the screening test for lupus. Anti-dsDNA and anti-Smith antibodies help confirm it. If scleroderma or myositis is suspected, a separate panel of antibodies comes into play. The rheumatologist picks the panel based on the clinical picture, not as a one-size-fits-all screen.

Inflammatory Markers

CRP and ESR (erythrocyte sedimentation rate) measure general inflammation. They are useful for tracking disease activity over time, and CRP in particular correlates moderately with synovial inflammation seen on MRI. That said, these markers have real limitations. In routine clinical practice, CRP and ESR correlate only weakly with many standard measures of disease activity in rheumatoid arthritis, lupus, and osteoarthritis. In other words, normal CRP does not rule out active disease, and high CRP does not always mean things are getting worse. The rheumatologist interprets these numbers alongside everything else, not in isolation.

Genetic Testing

If a type of spondyloarthritis is suspected, particularly ankylosing spondylitis, the doctor may order an HLA-B27 test. This is a blood test that detects a specific genetic marker. More than 90% of people with ankylosing spondylitis carry HLA-B27, but only about 1% of people who carry the gene ever develop the disease. That asymmetry means the test is most useful when combined with symptoms and imaging, not on its own. A positive result raises the probability of the diagnosis; a negative result lowers it but does not eliminate it. The rheumatologist will not diagnose or rule out spondyloarthritis on this test alone.

Imaging You Might Get

Not every first visit involves imaging, but it is common. The choice of imaging depends on what the doctor is looking for.

Plain X-rays of the hands, wrists, or feet are often the starting point. They show established bone erosions and joint-space narrowing, both signs of damage that has already occurred. For conditions like osteoporosis, dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone density and remains the basis for the World Health Organization’s definition of osteoporosis.

Ultrasound is increasingly used right in the rheumatology office. It can spot joint effusions, inflamed synovial tissue, and soft-tissue injuries that X-rays miss, and it helps guide needle placement for joint injections or fluid aspiration. MRI may be ordered separately, particularly when the doctor needs to see early inflammation or bone marrow edema before damage shows up on X-ray. MRI and newer modalities can also evaluate bone quality in ways that DXA cannot.

Joint Aspiration and Injections

If you have a swollen, painful joint, the rheumatologist may aspirate it during the visit. Joint aspiration, or arthrocentesis, involves inserting a needle into the joint space to withdraw fluid. It sounds alarming but is generally quick and done with local numbing. The procedure serves two purposes: diagnosis and relief. Removing excess fluid often reduces pain and pressure immediately.

The fluid itself goes to the lab for analysis. Synovial fluid analysis is the definitive way to diagnose septic arthritis and crystal-related conditions like gout and pseudogout. Detecting uric acid or calcium pyrophosphate crystals, even from a joint that is not currently inflamed, allows a precise diagnosis. Current recommendations emphasize that arthrocentesis should be performed whenever there is an unexplained joint effusion, especially if infection or crystals are suspected, because a septic joint is a medical emergency.

After draining a joint, the doctor may inject a corticosteroid into the same spot to calm inflammation. This is common during both initial and follow-up visits.

When Everything Comes Back “Normal”

One of the more frustrating scenarios is having clear symptoms but normal blood work. This happens more often than you might expect. Seronegative rheumatoid arthritis, where both rheumatoid factor and anti-CCP antibodies are negative, is a well-recognized form of the disease. Its distinguishing features remain largely unclear, and if it is not properly recognized, patients can miss the early treatment window that leads to better outcomes. The same is true for spondyloarthritis, where inflammatory markers can be completely normal during active disease.

If your labs are negative but your symptoms and physical exam are suspicious, the rheumatologist will not simply send you home. Imaging, clinical criteria, and repeat testing over time all contribute to the diagnostic picture. A diagnosis of a rheumatic disease is rarely made on a single test. It is built from a pattern of evidence that may take more than one visit to assemble.

How to Prepare for Your Visit

A little preparation can shorten your visit and improve its quality. One clinic found that standardizing a preparation checklist reduced the visit cycle time by ten minutes for new patients and five minutes for returning patients, with the rheumatologist also noting improved patient preparedness. Practical steps include:

  • Symptom diary: note which joints hurt, when, and what makes it better or worse. Track morning stiffness duration in minutes.
  • Medication list: bring every prescription, over-the-counter drug, and supplement you take, including doses.
  • Past records: any previous lab results, X-rays, or specialist notes. If your doctor sent a referral, confirm that the rheumatologist’s office has it.
  • Questions: write down what you want to ask. First visits cover a lot of ground, and it is easy to forget things in the moment.

There is also growing interest in patient-reported outcome measures, essentially structured questionnaires that you fill out about your symptoms. A systematic review found that using these tools was linked to improvements in symptom control and facilitated shared decision-making between patients and doctors. If the office sends you forms ahead of time, filling them out thoroughly is worth the effort.

Follow-Up Visits and Drug Monitoring

If you are started on medication, your rheumatology visits will follow a recurring rhythm. Most disease-modifying drugs require regular blood monitoring to watch for side effects. A review of monitoring practices found that the recommended interval between blood tests is typically about three months for the most commonly used drugs like methotrexate and thiopurines. These blood draws check liver function, kidney function, blood cell counts, and lipid levels depending on which medication you take.

Follow-up visits themselves are shorter than the initial one. The rheumatologist will reassess your joints, review your labs, ask how you are tolerating the medication, and adjust the treatment plan. If a drug is not controlling your disease adequately or is causing side effects, the plan shifts. This iterative process is why rheumatology tends to be an ongoing relationship rather than a one-and-done consultation.

The Broader Care Team

You may meet more than just the rheumatologist. Many rheumatology departments operate as multidisciplinary teams that can include specialist nurses, physiotherapists, occupational therapists, and podiatrists. Specialist nurses in particular often serve as the main point of contact for patient education, covering not only disease and medication information but also lifestyle strategies like smoking cessation and pregnancy planning. If you have questions you did not get to ask the doctor, the nurse is often the person to call.

For younger patients, the transition from pediatric to adult rheumatology is a meaningful shift. It involves more than just changing doctors; the entire care model changes, with less hand-holding and broader expectations around self-management. Young people who lack clear information about this change often find it especially challenging.

Telemedicine Rheumatology Visits

Since the pandemic, many rheumatology practices offer video visits for follow-up appointments. Several small studies suggest that telemedicine does not lead to worse outcomes compared with in-person visits, and patients generally report high satisfaction. Disease activity tools like DAS28 and CDAI can be calculated using patient-reported joint counts, making remote monitoring feasible.

During a video visit, the rheumatologist may coach you through examining your own joints on camera, showing you how to check for swelling and tenderness using a standardized approach. Rashes and other visible signs can be shown on video for the doctor’s assessment. The main limitation is that the physician cannot feel your joints. For a first visit or when a new diagnosis is in question, in-person appointments remain the standard.

Insurance and Prior Authorization Delays

If the rheumatologist prescribes a biologic or another specialty medication, you may encounter prior authorization, the process by which your insurer approves (or denies) coverage before treatment starts. This step adds real delays. A cohort study found that patients who required prior authorization for infused medications waited a median of 31 days to receive treatment, compared with 27 days for those who did not need authorization. For the roughly one in five patients whose authorization was initially denied, the median wait stretched to 50 days.

These delays matter because early, aggressive treatment of inflammatory arthritis tends to produce the best long-term results. If you are told your medication needs prior authorization, ask the office what the expected timeline is, whether they have submitted the request, and what happens if it gets denied. Most rheumatology offices have staff dedicated to navigating these approvals, and knowing the process can reduce your anxiety while you wait.